Vessel Formation Is Induced Prior to the Appearance of Cartilage in BMP-2-Mediated Heterotopic Ossification

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.
Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research (Impact Factor: 6.83). 10/2009; 25(5):1147-56. DOI: 10.1359/jbmr.091031
Source: PubMed


Heterotopic ossification (HO), or endochondral bone formation at nonskeletal sites, often results from traumatic injury and can lead to devastating consequences. Alternatively, the ability to harness this phenomenon would greatly enhance current orthopedic tools for treating segmental bone defects. Thus, understanding the earliest events in this process potentially would allow us to design more targeted therapies to either block or enhance this process. Using a murine model of HO induced by delivery of adenovirus-transduced cells expressing bone morphogenetic protein 2 (BMP-2), we show here that one of the earliest stages in this process is the establishment of new vessels prior to the appearance of cartilage. As early as 48 hours after induction of HO, we observed the appearance of brown adipocytes expressing vascular endothelial growth factors (VEGFs) simultaneous with endothelial progenitor replication. This was determined by using a murine model that possesses the VEGF receptor 2 (Flk1) promoter containing an endothelial cell enhancer driving the expression of nuclear-localized yellow fluorescent protein (YFP). Expression of this marker has been shown previously to correlate with the establishment of new vasculature, and the nuclear localization of YFP expression allowed us to quantify changes in endothelial cell numbers. We found a significant increase in Flk1-H2B::YFP cells in BMP-2-treated animals compared with controls. The increase in endothelial progenitors occurred 3 days prior to the appearance of early cartilage. The data collectively suggest that vascular remodeling and growth may be essential to modify the microenvironment and enable engraftment of the necessary progenitors to form endochondral bone.

Download full-text


Available from: Francis H Gannon
    • "The Sox9 gene, which belongs to a family of genes known as SOX and can be found in the chromosome region 17q24II-25,7 is crucial to the embryonic development in the early stages.8 Sox9 is a transcription factor that has C-terminal high-mobility group (HMG) domain and N-terminal transactivation domain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sox9 is an operon that positively regulates the transcription of type II collagen. The generation of type II collagen plays a critical role in the healing process of the bone-tendon junction (BTJ). Sox9 was injected into an established bone-tendon healing model in order to observe its effect on the healing by determining the biomechanical properties of the BTJ. In addition, the recombinant adenovirus Sox9 was used to transduce the animal model samples and in vivo observations of the effect of the adenovirus-mediated Sox9 transduction as well as its promotion of the healing properties were made. Sox9 was not only able to promote the healing, but also increased the biomechanical strength. The recombinant Sox9 delivered by adenoviral vector can be expressed at a high level in the damaged tissues of the bone-tendon junction, which can stimulate the production of type II collagen and improve the healing of the BTJ. Based on the results of this study, we considered that gene therapy may be applicable in the healing process of the bone-tendon junction.
    No preview · Article · Mar 2014 · Indian Journal of Orthopaedics
  • Source
    • "Angiogenesis is an important part of the bone repair process and is crucial for the supply of nutrients to developing cells along with incoming new cells that contribute to the process. VEGF has gained considerable interest in orthopaedics based on a number of reports that VEGF promotes neovascularization and growth of bone in animal models and during distraction osteogenesis [7, 22, 23, 25, 30–33]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The combined delivery of mesenchymal stem cells (MSCs), vascular endothelial growth factor (VEGF), and bone morphogenetic protein (BMP) to sites of bone injury results in enhanced repair compared to the administration of a single factor or a combination of two factors. Based on these findings, we hypothesized that coexpression of VEGF and BMP-6 genes would enhance the osteoblastic differentiation of rat bone-marrow-derived stem cells (rMSCs) and osteogenesis by comparison to rMSCs that do not express VEGF and BMP-6. We prepared a GFP tagged adenovirus vector (Ad-VEGF+BMP-6) that contained DNA encoding the hVEGF and hBMP-6 genes. rMSCs were transduced with the virus, and the successful transduction was confirmed by green fluorescence and by production of VEGF and BMP-6 proteins. The cells were cultured to assess osteoblastic differentiation or administered in the Fischer 344 rats to assess bone formation. Mineralization of rMSCs transduced with Ad-VEGF+BMP-6 was significantly enhanced over the nontransduced rMSCs. Only transduced rMSCs could induce osteogenesis in vivo , whereas Ad-VEGF+BMP-6 or nontransduced rMSCs alone did not induce osteogenesis. The data suggests that the combined delivery of MSCs, VEGF, and BMP-6 is an attractive option for bone repair therapy.
    Full-text · Article · Feb 2013
  • Source
    • "At this point of time, the fact that BMP-2 induces inflammation is indisputable. We also know that along with this potent inflammatory process, BMP-2 stimulates the local formation of brown fat (with the production of heat and water via uncoupled mitochondrial activity) and ultimately leads to cartilage formation, neovascularization, and bone formation [2] [3] [4]. Very recent work has strongly suggested that there is a direct action of BMP-2 on peripheral nerves in a process that includes the direct induction of neuroinflammation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: COMMENTARY ON: Dmitriev AE, Lehman RA Jr., Symes AJ. Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system. Spine J 2011;11:500–5 (in this issue).
    Full-text · Article · Jun 2011 · The spine journal: official journal of the North American Spine Society
Show more